Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Armin Ghobadi

Armin Ghobadi

MD
Washington University School of Medicine in St. Louis
CTX112, a next-generation allogeneic CD19 CAR-T product, for treating R/R B-cell malignancies 2:39
CTX112, a next-generation allogeneic CD19 CAR-T product, for treating R/R B-cell malignancies
Armin Ghobadi • 8 Dec 2024
Updated results of the ALLELE trial: tabelecleucel for Epstein–Barr virus-driven PTLD 3:58
Updated results of the ALLELE trial: tabelecleucel for Epstein–Barr virus-driven PTLD
Armin Ghobadi • 8 Dec 2024
Phase II results of WU-CART-007, an allogeneic CAR T-cell targeting CD7, in R/R T-ALL/LBL 2:17
Phase II results of WU-CART-007, an allogeneic CAR T-cell targeting CD7, in R/R T-ALL/LBL
Armin Ghobadi • 8 Dec 2024
The content of VJHemOnc is intended for healthcare professionals